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PHACE syndrome is a rare neurocutaneous disorder, with a complex pathogenesis. It 
presents with a large facial hemangioma associated with anomalies of the posterior fossa of 
the brain, arterial anomalies, cardiac anomalies, coarctation of the aorta, and eye 
anomalies. Ocular abnormalities are rare. We report the first published case of an infant 
with PHACE syndrome and Peters anomaly. 
Case Report 
A 6-week-old girl presented at Indiana University Health, Indianapolis, with a history of left 
facial erythema that appeared shortly after birth and was initially attributed to birth trauma. 
During the first few weeks of life, she developed more prominent erythema, scattered 
erythematous papules, and telangiectasia on the left upper face. The patient was also noted to 
have a cloudy left cornea and was initially referred to pediatric ophthalmology to rule out 
glaucoma associated with possible Sturge Weber syndrome. On examination, a large facial 
hemangioma involving the left upper and lower eyelids causing nearly complete ptosis was 
present (Figure 1A). Fixation and following acuity was present in the right eye but absent on the 
left. Complete examination of the right eye, including anterior segment and dilated fundus 
examination, was normal. The left eye had a dense central corneal opacity approximately 6 mm 
in diameter that precluded any view of the pupil, lens, or posterior segment (Figure 1A, inset). 
Iridocorneal adhesions were noted, with iris strands attached to the peripheral edges of the 
corneal opacity at the 11:00, 3:00, and 5:00 o’clock positions. B-scan ultrasonography showed a 
normal posterior segment in the left eye. Ultrasound biomicroscopy was performed to evaluate 
the anterior segment: no anterior polar or other lens opacity was noted (Figure 1B). Intraocular 
pressure (IOP) was 8 mm Hg in right eye and 11 mm Hg in left eye. A diagnosis of Peters 
anomaly was made.  
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Because of the large facial segmental hemangioma, the patient was admitted to the 
hospital for further workup and treatment. To rule out PHACE syndrome, an echocardiogram 
and magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) of the head 
and neck were performed. Echocardiogram showed a small patent foramen ovale versus 
secundum atrial septal defect, with left to right shunting. The MRI/MRA showed persistent 
bilateral tortuosity of the internal carotid arteries, no evidence of intracranial vascular 
malformations, and multiple hemangiomas of the left face, left orbit, left neck, and left posterior 
mediastinum. Direct laryngoscopy also showed a subglottic hemangioma.  
On admission to the hospital, the patient was treated with prednisolone  
2 mg/kg/day and ranitidine 7.5 mg/kg/day until cerebral imaging could rule out critical stenosis 
and dysplasia of the intracranial vasculature before starting propranolol. Symptoms of worsening 
gastroesophageal reflux necessitated increasing ranitidine to 10 mg/kg/day. The patient 
experienced respiratory stridor at the outset of admission, and MRI/MRA of the head and neck 
could not be performed under sedation until hospital day 6. At that time oral propranolol was 
initiated at a dosage of 0.5 mg/kg/day and titrated to 2 mg/kg/day. Prednisolone was continued at 
2 mg/kg/day, and the IOP was not monitored daily. 
The ptosis completely resolved, and the hemangioma became flat, with residual 
telangectasias. The patient was weaned off prednisolone over the subsequent 4 months. At 1 year 
of age the propranolol was also weaned, but cessation resulted in the development of inspiratory 
stridor attributed to rebound growth of the subglottic hemangioma. Propranolol was restarted, 
and at 1 year of age the dosage of propranolol remained 1.45 mg/kg/day. 
The patient underwent a surgical procedure to sever the iridocorneal adhesions at the age 
of 2 months, and she continues to be followed by both dermatology and ophthalmology. The 
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corneal opacity has cleared to the point where a faint red reflex is present, and no glaucoma has 
developed. In view of the right eye being normal, a conservative approach has been taken with 
regards to surgery of the involved eye; specifically, no penetrating keratoplasty has been 
recommended. 
Discussion 
PHACE syndrome (OMIM 606519) is a rare neurocutaneous disorder, with a complex 
pathogenesis. It presents with a large facial hemangioma (≥5 cm) associated with anomalies of 
the posterior fossa of the brain, arterial anomalies, cardiac anomalies, coarctation of the aorta, 
and eye anomalies. A multicenter study assessing 108 patients with large facial hemangiomas 
≥22 cm2 reported that nearly 1/3 had PHACE syndrome, and most demonstrated at least one 
extracutaneous finding.1 The most common manifestation was arterial anomalies of the 
cerebrovasculature (91%), followed by cardiac anomalies (67%). Ocular abnormalities were 
relatively uncommon, seen in only 8 patients (7.4%).1 Among the diagnostic criteria for PHACE 
syndrome, ocular anomalies include persistent fetal vasculature, persistent hyperplastic primary 
vitreous, retinal vascular anomalies, morning glory disk anomaly, optic nerve hypoplasia, and 
peripapillary staphyloma.1 Other ocular anomalies are considered minor criteria and include: 
sclerocornea, cataract, coloboma, and microphthalmia.1 Most eye findings seen in PHACE are 
secondary to the primary vascular and neurologic anomalies.2 These patients have an increased 
risk for amblyopia resulting from occlusive, strabismus, or refractive etiologies.3 To our 
knowledge, this is the first reported case of a child with PHACE syndrome and Peters anomaly.  
Peters anomaly is a congenital central corneal opacity, with corresponding defects in the 
posterior stroma, endothelium and Descemet’s membrane.4 Iridolenticulocorneal adhesions of 
variable degree are also present.5 The corneal endothelial layer, which is absent in Peters 
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anomaly, is derived from neural crest cells. The absence of this layer in Peters anomaly is 
believed to be from defective neural crest cell migration, because they fail to reach the central 
cornea.5 Given that anomalies of the anterior circulation outnumber posterior circulation 
anomalies, it is hypothesized the etiology of PHACE syndrome is due to neural crest cells.6 
Peters anomaly can be seen alone, with other ocular malformations, or with anomalies of 
well-defined syndromes.7 Midline body structures are often involved; common anomalies are 
cleft lip/palate, congenital heart defects, genitourinary abnormalities, pilonidal cysts, spina 
bifida, sacral hypoplasia, anal atresia, and vesicocolonic fistula.7 Peters-plus syndrome is defined 
as Peters’ anomaly, congenital cardiac defects, craniofacial dysplasia, cleft lip/palate, skeletal 
changes, and developmental delay.4 
 Our patient demonstrated Peters anomaly ipsilateral to segmental facial hemangioma and 
cerebrovascular anomalies indicating a potential “field effect,” given the proximity of the 
findings. The association of Peters anomaly and PHACE syndrome may be a coincidental 
finding in our patient; however, the spatial relationship to a segmental hemangioma distributed in 
the frontotemporal region that corresponds to patterns of neural crest migration suggests a causal 
relationship. Winter and colleagues6 have hypothesized that the insult causing PHACE syndrome 
occurs during the first trimester of pregnancy, given the developmental timing of the involved 
embryonic structures. Similarly, the critical event leading to Peters anomaly is believed to occur 
in the first trimester, when the anterior chamber is formed.8 Further study is warranted to 
understand this potential association.  
Literature Search 
PubMed was searched in March and August 2016 for English-language articles using 
combinations of the following terms: PHACE syndrome, Peters anomaly, anterior segment 
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dysgenesis, and infantile hemangioma.  
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Legends 
FIG 1. A, Clinical photograph of 6-week-old girl at presentation showing large, segmental left-
sided facial hemangioma causing ptosis; there was a dense central corneal opacity in the left eye 
(inset). B, Ultrasound biomicroscopy image showing iridocorneal adhesions of Peters anomaly in 
the left eye. 
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